Atlas Trials

A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccines ChAdOx2 HAV and MVA in Healthy Adult Volunteers

Clinical trial NCT03027193 · COMPLETED

Trial details

NCT number
NCT03027193
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Crohn DiseaseMycobacterium Avium Subspecies Paratuberculosis
Start date
2017-03-15
Primary completion
2020-01-16
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.